GUAIFENESIN

Post-LOE

guaifenesin

ANDAORALTABLET, EXTENDED RELEASE
Approved
Sep 2017
Lifecycle
Post-LOE
Competitive Pressure
30/100
Clinical Trials
3

Mechanism of Action

Pharmacologic Class:

Expectorant

Clinical Trials (3)

NCT01576809Phase 3Completed

Warming Sensation Intensity and Acceptability of the Flavour, Local Tolerability of Paracetamol 500 mg + Phenylephrine 10mg + Guaifenesin 200 mg Syrup in Patients Suffering a Upper Respiratory Tract Infection (URTI)

Started Mar 2012
51 enrolled
Upper Respiratory Infections
NCT01562548N/ACompleted

Exploratory Efficacy Study of Guaifenesin in Upper Back Pain

Started Feb 2012
78 enrolled
Upper Back Pain
NCT01364467Phase 2Completed

The Effect of Oral Guaifenesin on Pediatric Chronic Rhinitis: A Pilot Study

Started May 2011
30 enrolled
Chronic Rhinitis